Prophylactic furosemide to prevent transfusion-associated circulatory overload: a randomized controlled study in rats

Area of Science:

• Cardiology
• Nephrology
• Critical Care Medicine

Background:

• Transfusion-associated circulatory overload (TACO) is a significant cause of transfusion-related complications.
• Current management of TACO relies on empirical furosemide administration.
• The preventative efficacy of furosemide against TACO remains under investigation.

Purpose of the Study:

• To investigate the preventative role of furosemide in a validated rat model of TACO.
• To assess the dose-response relationship of furosemide in mitigating TACO-induced hemodynamic changes.

Main Methods:

• A randomized controlled trial utilized a two-hit rat model to induce TACO.
• Anemic rats received placebo, low-dose (5 mg/kg), or high-dose (15 mg/kg) furosemide before transfusion.
• Left-ventricular end-diastolic pressure (LVEDP) was the primary outcome, with secondary hemodynamic and pulmonary assessments.

Main Results:

• Furosemide significantly reduced the increase in LVEDP post-transfusion compared to placebo (p=0.041).
• A dose-dependent effect was observed, with higher furosemide doses yielding greater reductions in LVEDP.
• While urine output increased, furosemide did not significantly alter preload, afterload, contractility, or systemic vascular resistance.

Conclusions:

• Furosemide demonstrates a rapid, dose-dependent ability to decrease hydrostatic pulmonary pressure following transfusion.
• These findings support the preventative use of furosemide in mitigating TACO.
• Further clinical studies are warranted to confirm these effects in human patients.